Tagged Articles

long-term use 30 articles

Lawsuit claims Johnson & Johnson should have warned consumers about ovarian cancer risk with baby powder

A woman suing consumer health care giant Johnson & Johnson alleging the company should have included ovarian cancer warnings on its baby powder says it is irrelevant that she never developed the disease; she still suffered financial injury from buying the product under false pretenses year after year. Plaintiff Barbara Mihalich’s response was aimed at Johnson & Johnson’s motion to dismiss her case and mischaracterize her claims as a personal injury lawsuit. Mihalich claims that she –and other women like her – would likely have never purchased the product had they known the powder could increase their risk of developing ... Read More

AL Supreme Court rules: Brand name drug makers liable for warnings on generic drug counterparts

Makers of brand-name medications can be held liable for warnings on generic drugs even if the generic was produced by another drug company, the Alabama Supreme Court ruled. A majority of the nine-member court upheld a 2013 decision, which was viewed as a defeat by business leaders in this mostly Republican state. The ruling is based on a federal lawsuit filed by Danny and Vick Weeks against five current and former drug makers alleging that long-term use of the heartburn drug metoclopramide, which was also sold under the brand name Reglan, caused a debilitating movement disorder known as tardive dyskinesia. ... Read More

Johnson and Johnson files motion to dismiss baby powder-ovarian cancer lawsuit

Johnson & Johnson filed a motion in Illinois court to dismiss a proposed class action lawsuit alleging the consumer health care company’s classic baby powder products increase the risk of ovarian cancer. Johnson & Johnson says plaintiff Barbara Mihalich has not developed ovarian cancer nor has she shown to suffer any injury from using the product, and thus has suffered no economic loss for which she should be compensated. She also did not claim that she bought the product to use for personal hygiene in her genital area, which the company says is the only use that the plaintiff claims ... Read More

Long-term use of antipsychotic Risperdal in children linked to reduced bone mass

Long-term use of the antipsychotic drug Risperdal in children can reduce bone mass and prevent bone growth, according to a new study presented at the American Society of Clinical Psychopharmacology’s annual meeting. Similar results were found in children treated long-term with antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. Risperdal, also known by the generic risperidone, is used to treat symptoms of schizophrenia, bipolar disorder, and irritability with autism. In 2007, the Food and Drug Administration (FDA) approved the medication for use in children and adolescents with those disorders, though the drug’s maker Janssen Pharmaceuticals had illegally marketed the medication to ... Read More

Controversial analysis suggests Actos may help protect users from dementia

The type 2 diabetes drug Actos could help ward off dementia, a new analysis has found. However, researcher say more analysis is needed as well as adverse side effects addressed before the medication can be recommended as a preventative measure. The analysis involved data from Germany’s biggest public health insurer, which included about 146,000 patients aged 60 or older. The patients were tracked from 2004 to 2010, during which time about 14,000 of them developed dementia. When prescriptions for Actos were factored into the analysis, researchers found that patients taking Actos had about a 6 percent decline in the likelihood ... Read More

Participants sought for study on long-term effects of type 2 diabetes drugs

People between 30 and 70 years of age diagnosed with type 2 diabetes within the past five years who take no medication to treat the chronic condition are being sought for a study evaluating long-term effectiveness of diabetes drugs. The study is being conducted at 37 sites across the country and aims to recruit about 5,000 participants. The study, called G.R.A.D.E. – the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study – will compare four medications, each combined with metformin. The National Institute of Diabetes, along with Digestive and Kidney Diseases of the National Institutes of Health, is funding ... Read More

Short-term use, lower doses of Actos linked to increased bladder cancer risk

People who have been treated with the type 2 diabetes medication Actos (pioglitazone) for more than six months may be at greater risk of developing bladder cancer, even if they were on a low dose, according to a new study published in the Journal of Korean Medical Science and reported by Cancer Monthly. In 2011, studies showed long-term use (12 months or greater) of Actos increased the risk for bladder cancer. As a result, some countries banned the drug. The U.S. Food and Drug Administration (FDA) ordered that Actos and its generic equivalents include a warning on their safety labels ... Read More

Experimental drug helps reduce symptoms of tardive dyskinesia

Patients with a movement disorder known as tardive dyskinesia saw a reduction in spasms after taking Neurocrine Biosciences’ experimental drug NBI-98854 for six weeks compared to patients taking a placebo. The drug company says it hopes the promising data will win Food and Drug Administration (FDA) approval to move forward with a late-stage study during the first half of the year. Tardive dyskinesia is a difficult to treat and often incurable neurological disorder that causes involuntary movements such as grimacing, tongue movements, lip smacking and puckering, pursing of the lips, and excessive eye blinking. The condition most often occurs as ... Read More

Rise in obesity rates puts more people at risk of serious health consequences

An estimated one-third of the world’s adult population is overweight or obese and at risk of developing diabetes and other serious health conditions, according to a new study by the Overseas Development Institute (ODI). “The evidence is well established: obesity, together with excessive consumption of fat and salt, is linked to the rising global incidence of non-communicable diseases including some cancers, diabetes, heart disease, and strokes,” the report states. The study found the biggest problem to be in developing countries, where an estimated 900 million are considered overweight – nearly three times as many as 1980. Comparatively, about 550 million ... Read More

Could your diabetes medication cause cancer?

Type 2 diabetes is a chronic condition that occurs when the body does not produce enough insulin to regulate glucose – or sugar – levels in the blood. If left uncontrolled, diabetes can lead to serious health complications including cardiovascular disease, kidney disease, dementia, amputations due to neuropathy, and blindness. People who are overweight and do not exercise regularly are at greater risk of developing type 2 diabetes. Many require medications to keep their blood sugar levels in check. These medications help millions of people manage their disease, but for some, there is a price – dangerous side effects. The warning ... Read More